ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

124
Analysis
Health Care • Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
•07 Sep 2025 07:43

Taiwan Top 50 ETF Rebalance: Another Inclusion for Caliway Biopharma & King Slide

Caliway Biopharma and King Slide are adds at the close on 19 Sep. Both stocks were added to a global index end August and Caliway has another...

Logo
771 Views
Share
•26 Aug 2025 05:30

Taiwan Top 50 ETF Rebalance Preview: Hat Trick for Caliway Biopharma?

There could be 2 changes for the ETF in Sep. Caliway and King Slide are inclusions to a global index at the close today. Passive trackers of...

Logo
631 Views
Share
•25 Aug 2025 19:35

Quiddity Leaderboard T50/​​​100 Sep25: Final Expectations; Tung Ho Steel Safe from TDIV Deletion

T100 and TDIV index member Tung Ho Steel Enterprise (2006 TT) is unlikely to be deleted from T100 or TDIV in September 2025.

Share
•24 Jul 2025 21:48

Quiddity Leaderboard T50/​​​100 Sep25: Tung Ho Steel TDIV Deletion Gets Closer than Before

Tung Ho Steel (2006 TT) will need to underperform other names by 13% to be an unconditional T100 DEL and get deleted from TDIV. However, there are...

Share
•14 Jul 2025 07:05

TWSE Short Interest Weekly (Jul 11th): Unimicron Technology, Zhen Ding Technology, Ase Industrial

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Unimicron Technology, Zhen Ding Technology, Ase...

Logo
392 Views
Share
x